Help desk · A plain-language guide to US care
A prescription is the start of the check.
Check the person, the medicine, and how to get an answer when something feels wrong.
The mistaken idea
It is a mistake to think that every version of tirzepatide is the same because it comes with a prescription.
Where the tirzepatide shortcut fails
As of 26 September 2026, compounded tirzepatide is not an FDA-approved generic version of the branded medicine.
The FDA is the US Food and Drug Administration. Compounding is the process of making a medicine to order, most often at a pharmacy. A generic medicine is an approved version that copies a brand-name medicine.
Check the name behind the screen
State medical boards make doctors' licence records public, along with records of action taken when a doctor breaks the rules.
Ask for the doctor's name and licence number. Use the state-board directory on the source desk to find the board's own search.
A record without public action tells you only that no such action is shown; it gives no score for the quality of care.
The FDA also directs readers to state pharmacy boards to check the pharmacy sending their medicine.
Get that pharmacy's full name. Check its licence as well as the licence of the person writing your prescription.
Ask which medicine is being discussed
As of 26 September 2026, no FDA-approved generic tirzepatide was available in the US.
For compounded medicines, the FDA does not review quality, safety, or whether they work before they reach patients.
The FDA confirmed the national tirzepatide injection shortage had ended on 19 December 2024.
As of 26 September 2026, regular pharmacies cannot keep making near-copies of a medicine that is already available unless an exception applies.
One exception covers a change for a single named patient when the person writing the prescription decides it makes an important difference in that patient's care.
Ask which change your care requires, and why an approved product cannot meet that need.
As of 26 September 2026, making medicine to order can still be legal, but the rules about who makes it and copying approved medicines still apply.
Ask the pharmacy to explain the rule that allows it to make the medicine you are being offered.
FDA registration means the place that makes medicine is on the FDA's register.
As of 26 September 2026, appearing on that register is not FDA approval of either the place or its medicine.
The FDA urges people to avoid research-only tirzepatide marketed for human use: its quality is not known, and it could be harmful.
Discuss problems before they happen
A label is the product's official medicine information.
The tirzepatide labels flag certain family cancer history, pregnancy plans, other diabetes medicines, and past stomach or gallbladder trouble as things to discuss.
Feeling sick to your stomach, diarrhea, vomiting, and constipation were common in studies of people taking Zepbound (tirzepatide).
The Zepbound label also describes severe stomach problems, kidney harm after fluid loss, and reports of serious allergic reactions.
The Mounjaro (tirzepatide) and Zepbound labels carry the FDA's strongest label alert, called a boxed warning, about tumors in the thyroid seen in rats.
Whether tirzepatide causes those tumors in people is unknown.
The labels say these medicines must not be used by anyone who has had the rare cancer called medullary thyroid cancer, or whose family has had it.
Keep that exact cancer name for the person writing your prescription to check. If the only detail you have is that a relative had cancer, ask them to check which kind.
The labels also rule out use by people with MEN 2, a rare condition that a parent can pass to a child.
MEN 2 is the condition's medical name.
If you do not recognize it, have the person writing your prescription check your family's medical history before deciding on treatment.
A past serious allergy to tirzepatide or another ingredient in the medicine also rules out its use.
Tirzepatide can reduce protection from birth control pills for a time, according to the Zepbound label.
Ask for an explanation from the person treating you: which warnings apply to your health history, and what action to take if a problem starts.
Severe allergic reactions need urgent help
A severe allergic reaction may cause fainting, a swollen face or tongue, or breathing trouble.
Call 911 or go to the nearest emergency room.
Questions to take into the conversation
Does a licence prove every product is approved?
No. As of 26 September 2026, a compounded medicine lacks FDA product approval even if it comes from a licensed pharmacy.
What if medicine arrives warm?
The FDA advises against using a delivered injection if it is warm or has had too little refrigeration to maintain its required temperature.
Before using it, ask the pharmacy that sent it to check whether it was kept cold enough.
Keep your questions together
Write the questions you want to take to a visit. Use this space for prompts, rather than a health record.
Saved notes stay in this browser. Anyone using the same browser can open them. Clearing browser data removes them.
If the Save my notes button does not work, copy your questions before leaving this page.